Cell-based immunotherapies for solid tumors: advances, challenges, and future directions
Cell-based immunotherapies, including CAR-T, CAR-NK, and TCR-T therapies, represent a transformative approach to cancer treatment by offering precise targeting of tumor cells. Despite their success in hematologic malignancies, these therapies encounter significant challenges in treating solid tumors...
Saved in:
| Main Authors: | Ting Zhao, Jinping You, Congyue Wang, Bo Li, Yuhan Liu, Mingjia Shao, Wuyang Zhao, Chuang Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1551583/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-armored-cell therapy in solid tumor treatment
by: Yan Liu, et al.
Published: (2024-11-01) -
Precision sniper for solid tumors: CAR-NK cell therapy
by: Sisi Li, et al.
Published: (2025-07-01) -
Effectiveness, Limitations, and Future Perspectives of CAR-T Cell Therapy in Solid Tumor Treatment: A Narrative Review
by: Dmytro Kowalczuk, et al.
Published: (2025-05-01) -
Natural Killer Cell and Extracellular Vesicle-Based Immunotherapy in Thyroid Cancer: Advances, Challenges, and Future Perspectives
by: Kruthika Prakash, et al.
Published: (2025-07-01) -
Novel strategies to overcome tumor immunotherapy resistance using CAR NK cells
by: Jun-Hui Guo, et al.
Published: (2025-05-01)